MarketCap
Facebook
X
TelegramCantel Medical Corp. Balance Sheet 2011-2026 | CMD
Annual Balance Sheet Cantel Medical Corp.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
781 M | 186 M | 103 M | 89.4 M | 87.6 M | 46.8 M | 48.7 M | 60.9 M | 59.8 M | 5.59 M |
Long Term Debt |
1.05 B | 221 M | 187 M | 126 M | 116 M | 78.5 M | 80.5 M | 85 M | 80 M | 24 M |
Total Non Current Liabilities |
1.16 B | 257 M | 220 M | 156 M | 144 M | 107 M | 104 M | 107 M | 104 M | 43.7 M |
Total Current Liabilities |
179 M | 151 M | 135 M | 107 M | 96.3 M | 70.6 M | 66.5 M | 59.2 M | 55.1 M | 43.4 M |
Total Liabilities |
1.34 B | 409 M | 355 M | 262 M | 240 M | 177 M | 171 M | 167 M | 159 M | 87.1 M |
Deferred Revenue |
26.2 M | 27.8 M | 28.6 M | 25.3 M | 20.2 M | 18.3 M | 16.1 M | 11.4 M | 8.11 M | 6.72 M |
Retained Earnings |
548 M | 539 M | 492 M | 408 M | 342 M | 287 M | 243 M | 204 M | 168 M | 139 M |
Total Assets |
2.07 B | 1.07 B | 964 M | 786 M | 695 M | 584 M | 536 M | 488 M | 435 M | 321 M |
All numbers in USD currency
Balance Sheet is a fundamental financial report of Cantel Medical Corp., providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
Balance sheet of other industry stocks – Medical instruments
| Issuer | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
- | - | $ 810 M |  USA |
 |
Milestone Scientific
MLSS
|
$ 0.32 | 1.78 % | $ 26.3 M | USA |
 |
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | USA |
 |
Alcon
ALC
|
$ 76.12 | 0.44 % | $ 40.4 B |  Schweiz |
 |
Ekso Bionics Holdings
EKSO
|
$ 11.18 | 1.73 % | $ 27.1 M | USA |
 |
STERIS plc
STE
|
$ 222.27 | 0.23 % | $ 21.9 B | USA |
 |
iRhythm Technologies
IRTC
|
$ 126.75 | 3.6 % | $ 4.06 B | USA |
 |
The Cooper Companies
COO
|
$ 64.56 | 0.22 % | $ 12.9 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | USA |
 |
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | USA |
 |
Repro Med Systems
KRMD
|
$ 4.06 | 2.53 % | $ 188 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | USA |
 |
Microbot Medical
MBOT
|
$ 2.17 | -1.36 % | $ 99.4 M |  Israel |
 |
Haemonetics Corporation
HAE
|
$ 61.14 | 1.93 % | $ 3.08 B | USA |
 |
electroCore
ECOR
|
$ 6.12 | -0.89 % | $ 51.9 K | USA |
 |
ICU Medical
ICUI
|
$ 123.04 | -1.43 % | $ 3.03 B | USA |
 |
Envista Holdings Corporation
NVST
|
$ 26.8 | 0.04 % | $ 4.5 B | USA |
 |
Isoray
ISR
|
- | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
$ 474.78 | -1.54 % | $ 169 B | USA |
 |
Glaukos Corporation
GKOS
|
$ 122.09 | 0.35 % | $ 5.91 B | USA |
 |
Masimo Corporation
MASI
|
$ 178.62 | -0.01 % | $ 9.52 B | USA |
 |
InfuSystem Holdings
INFU
|
$ 10.87 | 5.33 % | $ 224 M | USA |
 |
Teleflex Incorporated
TFX
|
$ 136.17 | -0.29 % | $ 6.08 B | USA |
 |
Merit Medical Systems
MMSI
|
$ 67.44 | -1.66 % | $ 3.99 B | USA |
 |
Utah Medical Products
UTMD
|
$ 67.69 | 0.77 % | $ 219 M | USA |
 |
Pulse Biosciences
PLSE
|
$ 22.92 | -0.43 % | $ 1.54 B | USA |
 |
West Pharmaceutical Services
WST
|
$ 302.34 | -1.16 % | $ 21.9 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
$ 11.88 | -0.29 % | $ 2.37 B | USA |
 |
Retractable Technologies
RVP
|
$ 0.64 | -2.14 % | $ 19.2 M | USA |
 |
Pro-Dex
PDEX
|
$ 51.58 | -1.0 % | $ 170 M | USA |
 |
LeMaitre Vascular
LMAT
|
$ 115.33 | 1.66 % | $ 2.61 B | USA |
 |
Predictive Oncology
POAI
|
- | - | $ 31.1 M | USA |
 |
STAAR Surgical Company
STAA
|
$ 26.33 | 2.57 % | $ 1.31 B | USA |
 |
BioLife Solutions
BLFS
|
$ 21.55 | 0.8 % | $ 993 M | USA |
 |
Stereotaxis
STXS
|
$ 1.94 | - | $ 176 M | USA |
 |
Baxter International
BAX
|
$ 18.25 | 0.5 % | $ 9.36 B | USA |
 |
ResMed
RMD
|
$ 221.51 | 0.81 % | $ 32.4 B | USA |
 |
AtriCure
ATRC
|
$ 29.3 | 0.07 % | $ 1.4 B | USA |
 |
Harvard Bioscience
HBIO
|
$ 6.53 | -4.88 % | $ 290 M | USA |
 |
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
$ 11.13 | 0.27 % | $ 455 M | USA |
 |
Becton, Dickinson and Company
BDX
|
$ 150.96 | -0.76 % | $ 43.4 B | USA |
 |
Nephros
NEPH
|
$ 2.98 | 3.83 % | $ 31 M | USA |
 |
OraSure Technologies
OSUR
|
$ 2.96 | -1.5 % | $ 218 M | USA |
 |
Repligen Corporation
RGEN
|
$ 118.28 | 0.58 % | $ 6.59 M | USA |